Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH
Jakob Bolinder, Oskar Ragnarsson, Gudmundur Johansson · 2026
Read Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH by Jakob Bolinder, Oskar Ragnarsson, Gudmundur Johansson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13432619.txt.
Description
Jakob Bolinder, Oskar Ragnarsson, and Gudmundur Johansson reviewed care in 2026 for 58 Swedish adults born with an adrenal gland fault that blocks a key hormone step. Care walks a line: too little steroid cover frees male-type hormones, while too much brings its own harm. Records at one university hospital spanned 2020 to 2024.
Half the group took daily doses above the mid-point of the range used for children, and a fifth ran their doses on a flipped day-night plan. Care stayed tailored to each person, with long-settled plans often left alone when no clear harm showed. One gap stood out: fewer than a third held a rescue shot kit for sick days, and barely a third of the highest-risk set held one. Yearly marker checks may also mislead, the authors warn.
Catalog record
| CREATOR | Jakob Bolinder, Oskar Ragnarsson, Gudmundur Johansson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8251 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |